233 related articles for article (PubMed ID: 31605345)
1. The Relationship Between Tumor Budding, Tumor Microenvironment, and Survival in Patients with Primary Operable Colorectal Cancer.
van Wyk HC; Roseweir A; Alexander P; Park JH; Horgan PG; McMillan DC; Edwards J
Ann Surg Oncol; 2019 Dec; 26(13):4397-4404. PubMed ID: 31605345
[TBL] [Abstract][Full Text] [Related]
2. The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
van Wyk HC; Park JH; Edwards J; Horgan PG; McMillan DC; Going JJ
Br J Cancer; 2016 Jul; 115(2):156-63. PubMed ID: 27299960
[TBL] [Abstract][Full Text] [Related]
3. Tumour invasiveness, the local and systemic environment and the basis of staging systems in colorectal cancer.
Park JH; van Wyk H; Roxburgh CSD; Horgan PG; Edwards J; McMillan DC
Br J Cancer; 2017 May; 116(11):1444-1450. PubMed ID: 28427085
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a tumor microenvironment-based prognostic score in primary operable colorectal cancer.
Park JH; McMillan DC; Powell AG; Richards CH; Horgan PG; Edwards J; Roxburgh CS
Clin Cancer Res; 2015 Feb; 21(4):882-8. PubMed ID: 25473000
[TBL] [Abstract][Full Text] [Related]
5. Budding and tumor-infiltrating lymphocytes - combination of both parameters predicts survival in colorectal cancer and leads to new prognostic subgroups.
Lang-Schwarz C; Melcher B; Haumaier F; Lang-Schwarz K; Rupprecht T; Vieth M; Sterlacci W
Hum Pathol; 2018 Sep; 79():160-167. PubMed ID: 29787819
[TBL] [Abstract][Full Text] [Related]
6. The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
Park JH; Richards CH; McMillan DC; Horgan PG; Roxburgh CSD
Ann Oncol; 2014 Mar; 25(3):644-651. PubMed ID: 24458470
[TBL] [Abstract][Full Text] [Related]
7. Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer.
Hatthakarnkul P; Pennel K; Alexander P; van Wyk H; Roseweir A; Inthagard J; Hay J; Andersen D; Maka N; Park J; Roxburgh C; Thuwajit C; McMillan D; Edwards J
J Pathol Clin Res; 2024 May; 10(3):e12374. PubMed ID: 38650367
[TBL] [Abstract][Full Text] [Related]
8. Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer.
Dawson H; Galuppini F; Träger P; Berger MD; Studer P; Brügger L; Zlobec I; Inderbitzin D; Lugli A
Hum Pathol; 2019 Mar; 85():145-151. PubMed ID: 30428391
[TBL] [Abstract][Full Text] [Related]
9. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer.
Marx AH; Mickler C; Sauter G; Simon R; Terracciano LM; Izbicki JR; Clauditz TS
Int J Colorectal Dis; 2020 Feb; 35(2):259-268. PubMed ID: 31838579
[TBL] [Abstract][Full Text] [Related]
10. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.
Lugli A; Kirsch R; Ajioka Y; Bosman F; Cathomas G; Dawson H; El Zimaity H; Fléjou JF; Hansen TP; Hartmann A; Kakar S; Langner C; Nagtegaal I; Puppa G; Riddell R; Ristimäki A; Sheahan K; Smyrk T; Sugihara K; Terris B; Ueno H; Vieth M; Zlobec I; Quirke P
Mod Pathol; 2017 Sep; 30(9):1299-1311. PubMed ID: 28548122
[TBL] [Abstract][Full Text] [Related]
12. Reporting of tumor budding in colorectal adenocarcinomas using ×40 objective: A practical approach for resource constrained set-ups.
Roy P; Datta J; Roy M; Mallick I; Mohandas M
Indian J Cancer; 2017; 54(4):640-645. PubMed ID: 30082550
[TBL] [Abstract][Full Text] [Related]
13. Pattern and Significance of Tumour Budding in Colorectal Carcinomas Using ITBCC Guidelines: a Low Resource Setting Practice Observation.
Ezenkwa US; Ogun GO; Bamiro OO; Mashor MI; Okolo CA; Adegoke OO; Ogunbiyi OJ
J Gastrointest Cancer; 2020 Sep; 51(3):1018-1023. PubMed ID: 31970654
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of perineural invasion in stages II and III colorectal cancer.
Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
[TBL] [Abstract][Full Text] [Related]
15. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
[TBL] [Abstract][Full Text] [Related]
17. Potential clinical scenarios of tumour budding in colorectal cancer.
Dawson H; Blank A; Zlobec I; Lugli A
Acta Gastroenterol Belg; 2019; 82(4):515-518. PubMed ID: 31950807
[TBL] [Abstract][Full Text] [Related]
18. Tumor budding assessed according to the criteria of the International Tumor Budding Consensus Conference determines prognosis in resected esophageal adenocarcinoma.
Lohneis P; Hieggelke L; Gebauer F; Ball M; Bruns C; Büttner R; Löser H; Quaas A
Virchows Arch; 2021 Mar; 478(3):393-400. PubMed ID: 32761393
[TBL] [Abstract][Full Text] [Related]
19. Tumor budding in colorectal carcinoma: An institutional interobserver reliability and prognostic study of colorectal adenocarcinoma cases.
Hacking S; Angert M; Jin C; Kline M; Gupta N; Cho M; Thomas R; Lee L; Chavarria H; Nasim M
Ann Diagn Pathol; 2019 Dec; 43():151420. PubMed ID: 31731034
[TBL] [Abstract][Full Text] [Related]
20. Tumour budding in solid cancers.
Lugli A; Zlobec I; Berger MD; Kirsch R; Nagtegaal ID
Nat Rev Clin Oncol; 2021 Feb; 18(2):101-115. PubMed ID: 32901132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]